Young-Eun Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young-Eun Kim has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Mi Ju Son
Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
10 shared publications - Anna Kim
KM Data Division, Korea Institute of Oriental Medicine
7 shared publications - Sumin Seo
Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
6 shared publications - Sungha Kim
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon, Republic of Korea
6 shared publications - Eunhee Lee
Department of Korean Obstetrics & Gynecology, College of Korean Medicine, Woosuk University
5 shared publications - Eunbyul Cho
Research Center of Traditional Korean Medicine, Wonkwang University, Republic of Korea
4 shared publications
Latest Publications
- Open Access
Korean Medicine for Aging Cohort (KoMAC) study—a prospective multicentre cohort in urban and rural Korea: cohort profile
Purpose: The KoMAC (Korean Medicine for Aging Cohort) study investigates health characteristics related to ageing from both conventional and Korean medicine (KM) perspectives through a prospective, multicentre cohort study that also serves as a platform for future embedded intervention studies. Participants: This study aimed to recruit 1000 adults aged 50–65 years from both urban (Iksan and surrounding areas, Jeonbuk Province) and rural (Jangheung and surrounding areas, Jeonnam Province) regions in Korea. Recruitment began in August 2023. The inclusion criteria were residence in the target region, literacy and written consent. Findings to date: Initial data showed regional differences in health behaviours and conditions; rural participants showed higher rates of alcohol consumption, smoking and childbirth experience among women, while urban participants showed lower pulmonary function and less favourable hearing thresholds. Ageing was associated with a general decline in physical and psychosocial function, particularly in women. KM-based phenotypic analysis revealed an age-related increase in kidney deficiency patterns and blood stasis, particularly in women. Emotional assessments indicated a decline in joy with age. Laboratory findings showed age-related increases in blood urea nitrogen levels in women, consistent with changes observed in KM-based phenotypes. Future plans: The KoMAC study will continue with annual follow-ups, and blood samples will be collected again at the final follow-up visit to identify ageing-related risk factors. Embedded randomised controlled trials will evaluate the effects of KM-based interventions on health outcomes. Trial registration number: Clinical Research Information Service (KCT0008863).
Open AccessKorean Medicine for Aging Cohort (KoMAC) study—a prospective multicentre cohort in urban and rural Korea: cohort profile
Purpose: The KoMAC (Korean Medicine for Aging Cohort) study investigates health characteristics related to ageing from both conventional and Korean medicine (KM) perspectives through a prospective, multicentre cohort study that also serves as a platform for future embedded intervention studies. Participants: This study aimed to recruit 1000 adults aged 50–65 years from both urban (Iksan and surrounding areas, Jeonbuk Province) and rural (Jangheung and surrounding areas, Jeonnam Province) regions in Korea. Recruitment began in August 2023. The inclusion criteria were residence in the target region, literacy and written consent. Findings to date: Initial data showed regional differences in health behaviours and conditions; rural participants showed higher rates of alcohol consumption, smoking and childbirth experience among women, while urban participants showed lower pulmonary function and less favourable hearing thresholds. Ageing was associated with a general decline in physical and psychosocial function, particularly in women. KM-based phenotypic analysis revealed an age-related increase in kidney deficiency patterns and blood stasis, particularly in women. Emotional assessments indicated a decline in joy with age. Laboratory findings showed age-related increases in blood urea nitrogen levels in women, consistent with changes observed in KM-based phenotypes. Future plans: The KoMAC study will continue with annual follow-ups, and blood samples will be collected again at the final follow-up visit to identify ageing-related risk factors. Embedded randomised controlled trials will evaluate the effects of KM-based interventions on health outcomes. Trial registration number: Clinical Research Information Service (KCT0008863).
- Open Access
- 16 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91706
Comparing 2-Hz and 100-Hz Electroacupuncture for Postoperative Musculoskeletal Pain: Protocol for a 2 × 2 Prospective Randomized Crossover Trial
Background: Postoperative pain after musculoskeletal surgery impedes early rehabilitation and reduces quality of life. Electroacupuncture is used as an adjunct for analgesia, but the optimal stimulation frequency and short-term response trajectory have not been established. Objective: The aim of this study is to compare frequency-dependent relative analgesic responses to bilateral ST36 to SP9 electroacupuncture at 2 Hz and 100 Hz and generate effect size and variability estimates to inform future definitive trials. Methods: This single-center, frequency-masked, active-comparator, 2 × 2 prospective randomized crossover trial will enroll 30 adults (aged 19-80 years) experiencing pain (numerical rating scale [NRS] score≥4) after musculoskeletal surgery. Participants will undergo two 15-minute electroacupuncture sessions at bilateral ST36 to SP9 (2 Hz and 100 Hz) separated by a washout period of at least 7 days. Participants will not be informed of the assigned stimulation frequency or treatment sequence. Results: Participant recruitment began in September 2025, and data collection is expected to be completed by August 2026. Data analysis will begin after database finalization in late 2026, with primary findings submitted for publication in April 2027. The primary outcomes are baseline-adjusted changes in pain NRS scores at 15 minutes and 2 hours after each intervention. Secondary outcomes include pain NRS scores immediately after and at 1, 4, and 24 hours after electroacupuncture; pain location and quality; photoplethysmography-derived pulse rate variability, used as a surrogate for heart rate variability; radial pulse tonometry parameters; and wrist-worn activity metrics. Conclusions: This protocol describes an active-comparator crossover trial designed to estimate relative immediate and short-term analgesic responses to 2-Hz vs 100-Hz electroacupuncture and associated physiological measures in postoperative musculoskeletal pain. Because the trial does not include a sham, usual care, or no-additional-electroacupuncture control arm, it will not determine the absolute efficacy of electroacupuncture or separate specific effects from nonspecific contextual or placebo effects. Results from this trial will help optimize stimulation parameters and outcome assessments for larger, definitive efficacy trials. Trial Registration: Clinical Research Information Service KCT0011009; https://tinyurl.com/54phyep7 International Registered Report Identifier (IRRID): DERR1-10.2196/91706
- 16 June 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e91706
Open AccessComparing 2-Hz and 100-Hz Electroacupuncture for Postoperative Musculoskeletal Pain: Protocol for a 2 × 2 Prospective Randomized Crossover Trial
Background: Postoperative pain after musculoskeletal surgery impedes early rehabilitation and reduces quality of life. Electroacupuncture is used as an adjunct for analgesia, but the optimal stimulation frequency and short-term response trajectory have not been established. Objective: The aim of this study is to compare frequency-dependent relative analgesic responses to bilateral ST36 to SP9 electroacupuncture at 2 Hz and 100 Hz and generate effect size and variability estimates to inform future definitive trials. Methods: This single-center, frequency-masked, active-comparator, 2 × 2 prospective randomized crossover trial will enroll 30 adults (aged 19-80 years) experiencing pain (numerical rating scale [NRS] score≥4) after musculoskeletal surgery. Participants will undergo two 15-minute electroacupuncture sessions at bilateral ST36 to SP9 (2 Hz and 100 Hz) separated by a washout period of at least 7 days. Participants will not be informed of the assigned stimulation frequency or treatment sequence. Results: Participant recruitment began in September 2025, and data collection is expected to be completed by August 2026. Data analysis will begin after database finalization in late 2026, with primary findings submitted for publication in April 2027. The primary outcomes are baseline-adjusted changes in pain NRS scores at 15 minutes and 2 hours after each intervention. Secondary outcomes include pain NRS scores immediately after and at 1, 4, and 24 hours after electroacupuncture; pain location and quality; photoplethysmography-derived pulse rate variability, used as a surrogate for heart rate variability; radial pulse tonometry parameters; and wrist-worn activity metrics. Conclusions: This protocol describes an active-comparator crossover trial designed to estimate relative immediate and short-term analgesic responses to 2-Hz vs 100-Hz electroacupuncture and associated physiological measures in postoperative musculoskeletal pain. Because the trial does not include a sham, usual care, or no-additional-electroacupuncture control arm, it will not determine the absolute efficacy of electroacupuncture or separate specific effects from nonspecific contextual or placebo effects. Results from this trial will help optimize stimulation parameters and outcome assessments for larger, definitive efficacy trials. Trial Registration: Clinical Research Information Service KCT0011009; https://tinyurl.com/54phyep7 International Registered Report Identifier (IRRID): DERR1-10.2196/91706
- Open Access
- 17 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e87543
Safety of Postpartum Herbal Medicine in Primary Care Korean Medicine Clinics: Protocol for a Prospective, Multicenter, Registry-Based Observational Study
Background: Postpartum conditions significantly affect maternal and infant health. In South Korea, herbal medicine is commonly used for postpartum care in Korean medicine, but safety data remain limited. This study outlines a multicenter Korean medicine clinic registry designed to investigate treatment patterns and adverse events (AEs) associated with postpartum herbal medicine use. This primary care, practice-based research network registry will inform clinical decision-making and pharmacovigilance in postpartum care, supporting the quality and safety of care and guidance for comedication monitoring across community clinics. Objective: This study aims to establish a multicenter registry to investigate AEs and treatment patterns associated with postpartum herbal medicine use in Korean medicine clinics. Methods: This prospective observational registry will enroll postpartum patients receiving herbal medicine treatment from 15 Korean medicine clinics between July 2024 and June 2027, with a target sample size of 1000 participants. Patients within 6 months postpartum receiving herbal medicine will be included. Data will be collected for up to 8 weeks, including demographic information, medical history, herbal medicine prescriptions, AEs, and concomitant medication use. AEs are self-reported by patients, and causality is assessed using the World Health Organization Uppsala Monitoring Centre system and the Naranjo algorithm. Data collection and entry will follow standard operating procedures. Results: The registry was registered with the Clinical Research Information Service in June 2024 (KCT0009552). Recruitment began in July 2024 across 15 Korean medicine clinics and is planned to continue until June 2027 with a target enrollment of 1000 postpartum patients. Conclusions: This study represents the first large-scale, multicenter registry examining herbal medicine use during the postpartum period in Korean medicine clinics. By systematically collecting real-world data on AEs associated with postpartum herbal medicine use, we aim to establish a comprehensive safety database for individual herbal medicine and constituent herbs. The findings may support pharmacovigilance of herbal medicine and improve postpartum care outcomes for mothers and infants. Trial Registration: WHO ICTRP KCT0009552; https://trialsearch.who.int/?TrialID=KCT0009552 International Registered Report Identifier (IRRID): DERR1-10.2196/87543
- 17 April 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e87543
Open AccessSafety of Postpartum Herbal Medicine in Primary Care Korean Medicine Clinics: Protocol for a Prospective, Multicenter, Registry-Based Observational Study
Background: Postpartum conditions significantly affect maternal and infant health. In South Korea, herbal medicine is commonly used for postpartum care in Korean medicine, but safety data remain limited. This study outlines a multicenter Korean medicine clinic registry designed to investigate treatment patterns and adverse events (AEs) associated with postpartum herbal medicine use. This primary care, practice-based research network registry will inform clinical decision-making and pharmacovigilance in postpartum care, supporting the quality and safety of care and guidance for comedication monitoring across community clinics. Objective: This study aims to establish a multicenter registry to investigate AEs and treatment patterns associated with postpartum herbal medicine use in Korean medicine clinics. Methods: This prospective observational registry will enroll postpartum patients receiving herbal medicine treatment from 15 Korean medicine clinics between July 2024 and June 2027, with a target sample size of 1000 participants. Patients within 6 months postpartum receiving herbal medicine will be included. Data will be collected for up to 8 weeks, including demographic information, medical history, herbal medicine prescriptions, AEs, and concomitant medication use. AEs are self-reported by patients, and causality is assessed using the World Health Organization Uppsala Monitoring Centre system and the Naranjo algorithm. Data collection and entry will follow standard operating procedures. Results: The registry was registered with the Clinical Research Information Service in June 2024 (KCT0009552). Recruitment began in July 2024 across 15 Korean medicine clinics and is planned to continue until June 2027 with a target enrollment of 1000 postpartum patients. Conclusions: This study represents the first large-scale, multicenter registry examining herbal medicine use during the postpartum period in Korean medicine clinics. By systematically collecting real-world data on AEs associated with postpartum herbal medicine use, we aim to establish a comprehensive safety database for individual herbal medicine and constituent herbs. The findings may support pharmacovigilance of herbal medicine and improve postpartum care outcomes for mothers and infants. Trial Registration: WHO ICTRP KCT0009552; https://trialsearch.who.int/?TrialID=KCT0009552 International Registered Report Identifier (IRRID): DERR1-10.2196/87543
- Open Access
- 20 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Comparing 2-Hz and 100-Hz Electroacupuncture for Postoperative Musculoskeletal Pain: Protocol for a 2 × 2 Prospective Randomized Crossover Trial (Preprint)
BACKGROUND Postoperative pain after musculoskeletal surgery impedes early rehabilitation and reduces quality of life. Electroacupuncture is used as an adjunct for analgesia, but the optimal stimulation frequency and short-term response trajectory have not been established. OBJECTIVE The aim of this study is to compare frequency-dependent relative analgesic responses to bilateral ST36 to SP9 electroacupuncture at 2 Hz and 100 Hz and generate effect size and variability estimates to inform future definitive trials. METHODS This single-center, frequency-masked, active-comparator, 2 × 2 prospective randomized crossover trial will enroll 30 adults (aged 19-80 years) experiencing pain (numerical rating scale [NRS] score≥4) after musculoskeletal surgery. Participants will undergo two 15-minute electroacupuncture sessions at bilateral ST36 to SP9 (2 Hz and 100 Hz) separated by a washout period of at least 7 days. Participants will not be informed of the assigned stimulation frequency or treatment sequence. RESULTS Participant recruitment began in September 2025, and data collection is expected to be completed by August 2026. Data analysis will begin after database finalization in late 2026, with primary findings submitted for publication in April 2027. The primary outcomes are baseline-adjusted changes in pain NRS scores at 15 minutes and 2 hours after each intervention. Secondary outcomes include pain NRS scores immediately after and at 1, 4, and 24 hours after electroacupuncture; pain location and quality; photoplethysmography-derived pulse rate variability, used as a surrogate for heart rate variability; radial pulse tonometry parameters; and wrist-worn activity metrics. CONCLUSIONS This protocol describes an active-comparator crossover trial designed to estimate relative immediate and short-term analgesic responses to 2-Hz vs 100-Hz electroacupuncture and associated physiological measures in postoperative musculoskeletal pain. Because the trial does not include a sham, usual care, or no-additional-electroacupuncture control arm, it will not determine the absolute efficacy of electroacupuncture or separate specific effects from nonspecific contextual or placebo effects. Results from this trial will help optimize stimulation parameters and outcome assessments for larger, definitive efficacy trials. CLINICALTRIAL Clinical Research Information Service KCT0011009; https://tinyurl.com/54phyep7 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/91706
- 20 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessComparing 2-Hz and 100-Hz Electroacupuncture for Postoperative Musculoskeletal Pain: Protocol for a 2 × 2 Prospective Randomized Crossover Trial (Preprint)
BACKGROUND Postoperative pain after musculoskeletal surgery impedes early rehabilitation and reduces quality of life. Electroacupuncture is used as an adjunct for analgesia, but the optimal stimulation frequency and short-term response trajectory have not been established. OBJECTIVE The aim of this study is to compare frequency-dependent relative analgesic responses to bilateral ST36 to SP9 electroacupuncture at 2 Hz and 100 Hz and generate effect size and variability estimates to inform future definitive trials. METHODS This single-center, frequency-masked, active-comparator, 2 × 2 prospective randomized crossover trial will enroll 30 adults (aged 19-80 years) experiencing pain (numerical rating scale [NRS] score≥4) after musculoskeletal surgery. Participants will undergo two 15-minute electroacupuncture sessions at bilateral ST36 to SP9 (2 Hz and 100 Hz) separated by a washout period of at least 7 days. Participants will not be informed of the assigned stimulation frequency or treatment sequence. RESULTS Participant recruitment began in September 2025, and data collection is expected to be completed by August 2026. Data analysis will begin after database finalization in late 2026, with primary findings submitted for publication in April 2027. The primary outcomes are baseline-adjusted changes in pain NRS scores at 15 minutes and 2 hours after each intervention. Secondary outcomes include pain NRS scores immediately after and at 1, 4, and 24 hours after electroacupuncture; pain location and quality; photoplethysmography-derived pulse rate variability, used as a surrogate for heart rate variability; radial pulse tonometry parameters; and wrist-worn activity metrics. CONCLUSIONS This protocol describes an active-comparator crossover trial designed to estimate relative immediate and short-term analgesic responses to 2-Hz vs 100-Hz electroacupuncture and associated physiological measures in postoperative musculoskeletal pain. Because the trial does not include a sham, usual care, or no-additional-electroacupuncture control arm, it will not determine the absolute efficacy of electroacupuncture or separate specific effects from nonspecific contextual or placebo effects. Results from this trial will help optimize stimulation parameters and outcome assessments for larger, definitive efficacy trials. CLINICALTRIAL Clinical Research Information Service KCT0011009; https://tinyurl.com/54phyep7 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/91706
- Open Access
- 9 December 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (2) , 101280
Safety of herbal medicine in the postpartum period: A hospital-based single-arm, prospective observational study (SAFEHERE-PC)
- 9 December 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (2) , 101280
Open AccessSafety of herbal medicine in the postpartum period: A hospital-based single-arm, prospective observational study (SAFEHERE-PC)
- Open Access
- 11 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Safety of Postpartum Herbal Medicine in Primary Care Korean Medicine Clinics: Protocol for a Prospective, Multicenter, Registry-Based Observational Study (Preprint)
BACKGROUND Postpartum conditions significantly affect maternal and infant health. In South Korea, herbal medicine is commonly used for postpartum care in Korean medicine, but safety data remain limited. This study outlines a multicenter Korean medicine clinic registry designed to investigate treatment patterns and adverse events (AEs) associated with postpartum herbal medicine use. This primary care, practice-based research network registry will inform clinical decision-making and pharmacovigilance in postpartum care, supporting the quality and safety of care and guidance for comedication monitoring across community clinics. OBJECTIVE This study aims to establish a multicenter registry to investigate AEs and treatment patterns associated with postpartum herbal medicine use in Korean medicine clinics. METHODS This prospective observational registry will enroll postpartum patients receiving herbal medicine treatment from 15 Korean medicine clinics between July 2024 and June 2027, with a target sample size of 1000 participants. Patients within 6 months postpartum receiving herbal medicine will be included. Data will be collected for up to 8 weeks, including demographic information, medical history, herbal medicine prescriptions, AEs, and concomitant medication use. AEs are self-reported by patients, and causality is assessed using the World Health Organization Uppsala Monitoring Centre system and the Naranjo algorithm. Data collection and entry will follow standard operating procedures. RESULTS The registry was registered with the Clinical Research Information Service in June 2024 (KCT0009552). Recruitment began in July 2024 across 15 Korean medicine clinics and is planned to continue until June 2027 with a target enrollment of 1000 postpartum patients. CONCLUSIONS This study represents the first large-scale, multicenter registry examining herbal medicine use during the postpartum period in Korean medicine clinics. By systematically collecting real-world data on AEs associated with postpartum herbal medicine use, we aim to establish a comprehensive safety database for individual herbal medicine and constituent herbs. The findings may support pharmacovigilance of herbal medicine and improve postpartum care outcomes for mothers and infants. CLINICALTRIAL WHO ICTRP KCT0009552; https://trialsearch.who.int/?TrialID=KCT0009552 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/87543
- 11 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessSafety of Postpartum Herbal Medicine in Primary Care Korean Medicine Clinics: Protocol for a Prospective, Multicenter, Registry-Based Observational Study (Preprint)
BACKGROUND Postpartum conditions significantly affect maternal and infant health. In South Korea, herbal medicine is commonly used for postpartum care in Korean medicine, but safety data remain limited. This study outlines a multicenter Korean medicine clinic registry designed to investigate treatment patterns and adverse events (AEs) associated with postpartum herbal medicine use. This primary care, practice-based research network registry will inform clinical decision-making and pharmacovigilance in postpartum care, supporting the quality and safety of care and guidance for comedication monitoring across community clinics. OBJECTIVE This study aims to establish a multicenter registry to investigate AEs and treatment patterns associated with postpartum herbal medicine use in Korean medicine clinics. METHODS This prospective observational registry will enroll postpartum patients receiving herbal medicine treatment from 15 Korean medicine clinics between July 2024 and June 2027, with a target sample size of 1000 participants. Patients within 6 months postpartum receiving herbal medicine will be included. Data will be collected for up to 8 weeks, including demographic information, medical history, herbal medicine prescriptions, AEs, and concomitant medication use. AEs are self-reported by patients, and causality is assessed using the World Health Organization Uppsala Monitoring Centre system and the Naranjo algorithm. Data collection and entry will follow standard operating procedures. RESULTS The registry was registered with the Clinical Research Information Service in June 2024 (KCT0009552). Recruitment began in July 2024 across 15 Korean medicine clinics and is planned to continue until June 2027 with a target enrollment of 1000 postpartum patients. CONCLUSIONS This study represents the first large-scale, multicenter registry examining herbal medicine use during the postpartum period in Korean medicine clinics. By systematically collecting real-world data on AEs associated with postpartum herbal medicine use, we aim to establish a comprehensive safety database for individual herbal medicine and constituent herbs. The findings may support pharmacovigilance of herbal medicine and improve postpartum care outcomes for mothers and infants. CLINICALTRIAL WHO ICTRP KCT0009552; https://trialsearch.who.int/?TrialID=KCT0009552 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/87543
- Open Access
Cohort of allergic rhinitis evaluation of effectiveness and safety of herbal medicine (CARE-HM): protocol for the clinic-based multicentre Korean Medicine Registry
Background Allergic rhinitis (AR) is a common chronic inflammatory condition that significantly impairs quality of life (QoL) through symptoms such as nasal congestion, rhinorrhoea, sneezing and itching. Conventional treatments often show limitations, prompting interest in complementary therapies like herbal medicine (HM). HM is widely used in East Asian countries and has demonstrated potential in modulating immune responses and reducing AR symptoms. In Korea, a government pilot project expanded in 2024 to include AR under limited insurance coverage for HM, highlighting the need for robust clinical evidence on its safety and effectiveness. Methods and analysis This study is a multicentre, prospective registry conducted in 21 Korean Medicine (KM) clinics across Republic of Korea. The registry systematically collects real-world data on HM treatments for AR, focusing on patient demographics, treatment patterns and clinical outcomes. Participants meeting predefined criteria will receive HM or other KM therapies as part of routine care. Data will be collected bi-weekly for the first 4 weeks, with additional follow-ups at 6 and 12 months. Primary outcomes include changes in Total Nasal Symptom Score, QoL scores and safety evaluations, analysed using descriptive and inferential statistical methods. Ethics and dissemination This study was approved by the Institutional Review Board of Kyung Hee University on 11 December 2024 (Approval No. KHSIRB-24–631). The study findings will be published in peer-reviewed journals and presented at academic conferences. Trial registration number KCT0010172.
Open AccessCohort of allergic rhinitis evaluation of effectiveness and safety of herbal medicine (CARE-HM): protocol for the clinic-based multicentre Korean Medicine Registry
Background Allergic rhinitis (AR) is a common chronic inflammatory condition that significantly impairs quality of life (QoL) through symptoms such as nasal congestion, rhinorrhoea, sneezing and itching. Conventional treatments often show limitations, prompting interest in complementary therapies like herbal medicine (HM). HM is widely used in East Asian countries and has demonstrated potential in modulating immune responses and reducing AR symptoms. In Korea, a government pilot project expanded in 2024 to include AR under limited insurance coverage for HM, highlighting the need for robust clinical evidence on its safety and effectiveness. Methods and analysis This study is a multicentre, prospective registry conducted in 21 Korean Medicine (KM) clinics across Republic of Korea. The registry systematically collects real-world data on HM treatments for AR, focusing on patient demographics, treatment patterns and clinical outcomes. Participants meeting predefined criteria will receive HM or other KM therapies as part of routine care. Data will be collected bi-weekly for the first 4 weeks, with additional follow-ups at 6 and 12 months. Primary outcomes include changes in Total Nasal Symptom Score, QoL scores and safety evaluations, analysed using descriptive and inferential statistical methods. Ethics and dissemination This study was approved by the Institutional Review Board of Kyung Hee University on 11 December 2024 (Approval No. KHSIRB-24–631). The study findings will be published in peer-reviewed journals and presented at academic conferences. Trial registration number KCT0010172.
- Open Access
Safety of herbal medicine in the postpartum period of a Korean Medicine hospital and postpartum care centre: protocol of a registry study (SAFEHERE-PC)
Introduction Herbal medicines (HMs) are commonly used during the postpartum period in South Korea. However, the safety concerns associated with these medicines remain unresolved. This study aims to establish a registry of patients receiving HM treatment during the postpartum period and collect clinical data on treatments and adverse reactions to build evidence evaluating the safety of HM use. Methods and analysis This study will use a prospective observational registry, including patients admitted to the obstetrics and gynaecology department of the Woosuk University Korean Medicine Hospital’s postpartum care centre. A total of 1000 eligible patients visiting the Korean medicine hospital to recover from various postchildbirth symptoms and opting for HM treatment will be enrolled in the registry. For safety assessment, demographic information, medical history, adverse events (AEs) and treatment details, including HM prescription and concomitant medication usage, will be collected throughout the patient’s hospitalisation period at the postpartum care centre for analysis. Adverse reactions will be monitored daily during hospitalisation, and collected AEs will be analysed for causality using the WHO Uppsala Monitoring Centre causality assessment and the Naranjo Algorithm Score. Ethics and dissemination This study was approved by the Institutional Review Board of Woosuk University Korean Medicine Medical Center (WSOH IRB H2311-03-01). The results will be published in peer-reviewed journals or disseminated through conference presentations. Trial registration number KCT0009060.
Open AccessSafety of herbal medicine in the postpartum period of a Korean Medicine hospital and postpartum care centre: protocol of a registry study (SAFEHERE-PC)
Introduction Herbal medicines (HMs) are commonly used during the postpartum period in South Korea. However, the safety concerns associated with these medicines remain unresolved. This study aims to establish a registry of patients receiving HM treatment during the postpartum period and collect clinical data on treatments and adverse reactions to build evidence evaluating the safety of HM use. Methods and analysis This study will use a prospective observational registry, including patients admitted to the obstetrics and gynaecology department of the Woosuk University Korean Medicine Hospital’s postpartum care centre. A total of 1000 eligible patients visiting the Korean medicine hospital to recover from various postchildbirth symptoms and opting for HM treatment will be enrolled in the registry. For safety assessment, demographic information, medical history, adverse events (AEs) and treatment details, including HM prescription and concomitant medication usage, will be collected throughout the patient’s hospitalisation period at the postpartum care centre for analysis. Adverse reactions will be monitored daily during hospitalisation, and collected AEs will be analysed for causality using the WHO Uppsala Monitoring Centre causality assessment and the Naranjo Algorithm Score. Ethics and dissemination This study was approved by the Institutional Review Board of Woosuk University Korean Medicine Medical Center (WSOH IRB H2311-03-01). The results will be published in peer-reviewed journals or disseminated through conference presentations. Trial registration number KCT0009060.
- Open Access
- 29 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (9) , 918
Establishment of a Dataset for the Traditional Korean Medicine Examination in Healthy Adults
We established a protocol for the traditional Korean medicine examination (KME) and methodically gathered data following this protocol. Potential indicators for KME were extracted through a literature review; the first KME protocol was developed based on three rounds of expert opinions. The first KME protocol’s feasibility was confirmed, and data were collected over four years from traditional Korean medicine (KM) hospitals, focusing on healthy adults, using the final KME protocol. A literature review identified 175 potential core indicators, condensed into 73 indicators after three rounds of expert consultation. The first KME protocol, which was categorized under questionnaires and medical examinations, was developed after the third round of expert opinions. A pilot study using the first KME protocol was conducted to ensure its validity, leading to modifications resulting in the development of the final KME protocol. Over four years, data were collected from six KM hospitals, focusing on healthy adults; we obtained a dataset comprising 11,036 healthy adults. This is the first protocol incorporating core indicators of KME in a quantitative form and systematically collecting data. Our protocol holds potential merit in evaluating predisposition to diseases or predicting diseases.
- 29 April 2024
- Published by MDPI AG in Healthcare
- Vol. 12 (9) , 918
Open AccessEstablishment of a Dataset for the Traditional Korean Medicine Examination in Healthy Adults
We established a protocol for the traditional Korean medicine examination (KME) and methodically gathered data following this protocol. Potential indicators for KME were extracted through a literature review; the first KME protocol was developed based on three rounds of expert opinions. The first KME protocol’s feasibility was confirmed, and data were collected over four years from traditional Korean medicine (KM) hospitals, focusing on healthy adults, using the final KME protocol. A literature review identified 175 potential core indicators, condensed into 73 indicators after three rounds of expert consultation. The first KME protocol, which was categorized under questionnaires and medical examinations, was developed after the third round of expert opinions. A pilot study using the first KME protocol was conducted to ensure its validity, leading to modifications resulting in the development of the final KME protocol. Over four years, data were collected from six KM hospitals, focusing on healthy adults; we obtained a dataset comprising 11,036 healthy adults. This is the first protocol incorporating core indicators of KME in a quantitative form and systematically collecting data. Our protocol holds potential merit in evaluating predisposition to diseases or predicting diseases.